SANGAMO THERAPEUTICS, INC
Ticker: 1001233
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.44+148.3% | 0.58-96.8% | 18.31+184.3% | 6.44-87.0% | 49.41+13625.0% | 0.36-25.0% | 0.48-94.9% | 9.40 |
| Total Income | 1.44+148.3% | 0.58-96.8% | 18.31+184.3% | 6.44-87.0% | 49.41+13625.0% | 0.36-25.0% | 0.48-94.9% | 9.40 |
| EXPENSES | ||||||||
| Expenditure | 33.39-7.6% | 36.13-0.1% | 36.16+0.2% | 36.07-7.0% | 38.78+3.6% | 37.44-28.0% | 52.01-55.1% | 115.81 |
| Tax | 0.00+100.0% | -0.16-633.3% | 0.03-75.0% | 0.12+33.3% | 0.09+28.6% | 0.07-30.0% | 0.10-92.1% | 1.27 |
| PROFIT | ||||||||
| PBT | -31.00+11.7% | -35.09-75.8% | -19.96+34.5% | -30.48-383.3% | 10.76+129.8% | -36.05+26.4% | -48.99+52.4% | -102.89 |
| Net Profit | -31.00+11.3% | -34.93-74.7% | -19.99+34.7% | -30.60-386.8% | 10.67+129.5% | -36.13+26.4% | -49.09+52.9% | -104.16 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00%-2.46pp | -97.54%+2.46pp | -100.00%-121.51pp | 21.52%+121.51pp | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00%-121.60pp | 21.60%+121.60pp | -100.00% | -100.00% | -100.00% |
| EPS | -0.08+27.3% | -0.11-37.5% | -0.08+42.9% | -0.14-380.0% | 0.05+127.8% | -0.18+33.3% | -0.27+54.2% | -0.59 |
Corporate Events
No corporate events found.